Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Malignant Melanoma

  Free Subscription


15.09.2025

2 Ann Surg Oncol
1 Clin Cancer Res
1 J Surg Oncol
1 Melanoma Res
1 Oncogene


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. SHAFIQUE N, Farooq MS, Mattfeld V, Vargas GM, et al
    Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma.
    Ann Surg Oncol. 2025 Sep 12. doi: 10.1245/s10434-025-18314.
    PubMed         Abstract available

  2. BICHAKJIAN CK, Swetter SM, Carroll BT, Vidal NY, et al
    ICEMAN (Intelligent Choice of Excision Margin): A Randomized Controlled Trial of Adaptive Narrow Excision Versus Wide Excision for Adults with AJCC Stage I Cutaneous Melanoma.
    Ann Surg Oncol. 2025 Sep 8. doi: 10.1245/s10434-025-18282.
    PubMed        


    Clin Cancer Res

  3. SATO T, Butler MO, Piperno-Neumann S, Hassel JC, et al
    Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 patients.
    Clin Cancer Res. 2025 Sep 12. doi: 10.1158/1078-0432.CCR-25-1513.
    PubMed         Abstract available


    J Surg Oncol

  4. TAQI K, Jonsson EL, Assadzad GE, Stockley C, et al
    Superparamagnetic Iron Oxide Tracer: A Magnetic Match to Gold Standard in Melanoma Sentinel Lymph Node Biopsy-A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 Sep 10. doi: 10.1002/jso.70086.
    PubMed         Abstract available


    Melanoma Res

  5. FUCINA S, Lerda L, Del Fabro A, Reato C, et al
    Late peritoneal carcinomatosis from cutaneous melanoma mimicking ovarian cancer.
    Melanoma Res. 2025 Sep 10. doi: 10.1097/CMR.0000000000001064.
    PubMed         Abstract available


    Oncogene

  6. LEE YK, Heo HH, Park UH, Youn H, et al
    Tumor antigen PRAME promotes melanoma growth by inactivating p53 through the SIRT1-DBC1 axis.
    Oncogene. 2025 Sep 8. doi: 10.1038/s41388-025-03565.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.